215 related articles for article (PubMed ID: 31097707)
1. Optimal control nodes in disease-perturbed networks as targets for combination therapy.
Hu Y; Chen CH; Ding YY; Wen X; Wang B; Gao L; Tan K
Nat Commun; 2019 May; 10(1):2180. PubMed ID: 31097707
[TBL] [Abstract][Full Text] [Related]
2. Prediction of synergistic anti-cancer drug combinations based on drug target network and drug induced gene expression profiles.
Li X; Xu Y; Cui H; Huang T; Wang D; Lian B; Li W; Qin G; Chen L; Xie L
Artif Intell Med; 2017 Nov; 83():35-43. PubMed ID: 28583437
[TBL] [Abstract][Full Text] [Related]
3. The underlying molecular mechanism and potential drugs for treatment in papillary renal cell carcinoma: A study based on TCGA and Cmap datasets.
Pang JS; Li ZK; Lin P; Wang XD; Chen G; Yan HB; Li SH
Oncol Rep; 2019 Apr; 41(4):2089-2102. PubMed ID: 30816528
[TBL] [Abstract][Full Text] [Related]
4. Prognosis and regulation of an adenylyl cyclase network in acute myeloid leukemia.
Chen SL; Hu F; Wang DW; Qin ZY; Liang Y; Dai YJ
Aging (Albany NY); 2020 Jun; 12(12):11864-11877. PubMed ID: 32568101
[TBL] [Abstract][Full Text] [Related]
5. A Network of Conserved Synthetic Lethal Interactions for Exploration of Precision Cancer Therapy.
Srivas R; Shen JP; Yang CC; Sun SM; Li J; Gross AM; Jensen J; Licon K; Bojorquez-Gomez A; Klepper K; Huang J; Pekin D; Xu JL; Yeerna H; Sivaganesh V; Kollenstart L; van Attikum H; Aza-Blanc P; Sobol RW; Ideker T
Mol Cell; 2016 Aug; 63(3):514-25. PubMed ID: 27453043
[TBL] [Abstract][Full Text] [Related]
6. Network controllability solutions for computational drug repurposing using genetic algorithms.
Popescu VB; Kanhaiya K; Năstac DI; Czeizler E; Petre I
Sci Rep; 2022 Jan; 12(1):1437. PubMed ID: 35082323
[TBL] [Abstract][Full Text] [Related]
7. Changes in gene expression variability reveal a stable synthetic lethal interaction network in BRCA2-ovarian cancers.
Bueno R; Mar JC
Methods; 2017 Dec; 131():74-82. PubMed ID: 28754563
[TBL] [Abstract][Full Text] [Related]
8. Cancer network activity associated with therapeutic response and synergism.
Serra-Musach J; Mateo F; Capdevila-Busquets E; de Garibay GR; Zhang X; Guha R; Thomas CJ; Grueso J; Villanueva A; Jaeger S; Heyn H; Vizoso M; Pérez H; Cordero A; Gonzalez-Suarez E; Esteller M; Moreno-Bueno G; Tjärnberg A; Lázaro C; Serra V; Arribas J; Benson M; Gustafsson M; Ferrer M; Aloy P; Pujana MÀ
Genome Med; 2016 Aug; 8(1):88. PubMed ID: 27553366
[TBL] [Abstract][Full Text] [Related]
9. In silico perturbation of drug targets in pan-cancer analysis combining multiple networks and pathways.
Cava C; Castiglioni I
Gene; 2019 May; 698():100-106. PubMed ID: 30840853
[TBL] [Abstract][Full Text] [Related]
10. Drug target prioritization by perturbed gene expression and network information.
Isik Z; Baldow C; Cannistraci CV; Schroeder M
Sci Rep; 2015 Nov; 5():17417. PubMed ID: 26615774
[TBL] [Abstract][Full Text] [Related]
11. BMRF-MI: integrative identification of protein interaction network by modeling the gene dependency.
Shi X; Wang X; Shajahan A; Hilakivi-Clarke L; Clarke R; Xuan J
BMC Genomics; 2015; 16 Suppl 7(Suppl 7):S10. PubMed ID: 26099273
[TBL] [Abstract][Full Text] [Related]
12. Synergy from gene expression and network mining (SynGeNet) method predicts synergistic drug combinations for diverse melanoma genomic subtypes.
Regan-Fendt KE; Xu J; DiVincenzo M; Duggan MC; Shakya R; Na R; Carson WE; Payne PRO; Li F
NPJ Syst Biol Appl; 2019; 5():6. PubMed ID: 30820351
[TBL] [Abstract][Full Text] [Related]
13. MNBDR: A Module Network Based Method for Drug Repositioning.
Chen HG; Zhou XH
Genes (Basel); 2020 Dec; 12(1):. PubMed ID: 33375395
[TBL] [Abstract][Full Text] [Related]
14. Community assessment to advance computational prediction of cancer drug combinations in a pharmacogenomic screen.
Menden MP; Wang D; Mason MJ; Szalai B; Bulusu KC; Guan Y; Yu T; Kang J; Jeon M; Wolfinger R; Nguyen T; Zaslavskiy M; ; Jang IS; Ghazoui Z; Ahsen ME; Vogel R; Neto EC; Norman T; Tang EKY; Garnett MJ; Veroli GYD; Fawell S; Stolovitzky G; Guinney J; Dry JR; Saez-Rodriguez J
Nat Commun; 2019 Jun; 10(1):2674. PubMed ID: 31209238
[TBL] [Abstract][Full Text] [Related]
15. Complex regulation of autophagy in cancer - integrated approaches to discover the networks that hold a double-edged sword.
Kubisch J; Türei D; Földvári-Nagy L; Dunai ZA; Zsákai L; Varga M; Vellai T; Csermely P; Korcsmáros T
Semin Cancer Biol; 2013 Aug; 23(4):252-61. PubMed ID: 23810837
[TBL] [Abstract][Full Text] [Related]
16. Comparative analysis of protein interactome networks prioritizes candidate genes with cancer signatures.
Li Y; Sahni N; Yi S
Oncotarget; 2016 Nov; 7(48):78841-78849. PubMed ID: 27791983
[TBL] [Abstract][Full Text] [Related]
17. Diffusion mapping of drug targets on disease signaling network elements reveals drug combination strategies.
Xu J; Regan-Fendt K; Deng S; Carson WE; Payne PRO; Li F
Pac Symp Biocomput; 2018; 23():92-103. PubMed ID: 29218872
[TBL] [Abstract][Full Text] [Related]
18. Differential Co-Expression Analyses Allow the Identification of Critical Signalling Pathways Altered during Tumour Transformation and Progression.
Savino A; Provero P; Poli V
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33322692
[TBL] [Abstract][Full Text] [Related]
19. Synergistic Cytotoxicity of Renieramycin M and Doxorubicin in MCF-7 Breast Cancer Cells.
Tun JO; Salvador-Reyes LA; Velarde MC; Saito N; Suwanborirux K; Concepcion GP
Mar Drugs; 2019 Sep; 17(9):. PubMed ID: 31527453
[TBL] [Abstract][Full Text] [Related]
20. MICRAT: a novel algorithm for inferring gene regulatory networks using time series gene expression data.
Yang B; Xu Y; Maxwell A; Koh W; Gong P; Zhang C
BMC Syst Biol; 2018 Dec; 12(Suppl 7):115. PubMed ID: 30547796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
